Fig. 4From: Alternative donor peripheral blood stem cell transplantation for the treatment of high-risk refractory and/or relapsed childhood acute leukemia: a randomized trialThe factors of affecting 5-year OS rate between MSD and AD in one hundred eleven childhood acute leukemia; (a, b grade II–IV aGVHD; c, d donor-recipient ABO compatibility; e, f conditioning regimen; g, h CMV infection)Back to article page